John K. Cini Sonnet Bio Therapeutics Holdings, Inc. (SONN) insider trading activity

John K. Cini is Chief Scientific Officer of Sonnet BioTherapeutics Holdings, Inc.. Currently has a direct ownership of 14,116 shares of SONN, which is worth approximately $63,945. The most recent transaction as insider was on Jul 11, 2025, when has been sold 12,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.1K

567.11% 3M change

567.11% 12M change

Total Value Held $63,945

John K. Cini Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 11 2025	BUY Grant, award, or other acquisition	-	12,000 Added 45.95%	14,116 Common Stock
Dec 11 2023	BUY Grant, award, or other acquisition	-	1,888 Added 47.15%	2,116 Common Stock
Jan 07 2023	SELL Sale (or disposition) back to the issuer	-	18,551 Reduced 46.07%	21,720 Common Stock
Jan 07 2023	BUY Grant, award, or other acquisition	-	18,551 Added 31.54%	40,271 Common Stock
Dec 14 2022	BUY Grant, award, or other acquisition	-	18,551 Added 5.44%	322,652 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	80,034 Added 20.83%	304,101 Common Stock
May 25 2021	SELL Payment of exercise price or tax liability	$21,146 $1.51 p/Share	14,004 Reduced 5.88%	224,067 Common Stock

JKC

John K. Cini

Chief Scientific Officer

Princeton,, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SONN shares.

Notify only if

Value

Insider Trading

Get notified when an Sonnet Bio Therapeutics Holdings, Inc. insider buys or sells SONN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sonnet BioTherapeutics Holdings, Inc.

Track Activities on SONN

Account